1. MM Moore, D Clive, JC Hozier, BF Howard, AG Batson, NT Turner, J Sawyer. Analysis of trifluorothymidine-resistant (TFT) mutants of L5178Y/TK+/- mouse lymphoma cells. Mutat Res 151:161-174, 1985.

2. BF Blazak, FJ Los, CJ Rudd, WJ Caspary. Chromosome analysis of small and large L5178Y mouse lymphoma cell colonies: Comparison of trifluorothymidine-resistant and unselected cell colonies from mutagen-treated and control culture. Mutat Res 224:197-208, 1989.

3. ML Applegate, MM Moore, CB Broder, A Burrell, G Juhn, KL Kasweck, P-F Lin, A Wadhams, JC Hozier. Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc Natl Acad Sci U S A 87:51-57, 1990.

4. D Clive, P Glover, M Applegate, J Hozier. Molecular aspects of chemical mutagene-sis in L5178Y/tk+/- mouse lymphoma cells. Mutagenesis 5:191-197, 1990.

5. RD Combes, H Stopper, WJ Caspary. The use of L5178Y mouse lymphoma cells to assess the mutagenic, clastogenic and aneugenic properties of chemicals. Mutagene-sis 10:403-408, 1995.

6. L-S Zhang, M Honma, A Matsuoka, T Suzuki, T Sofuni, M Hayashi. Chromosome painting analysis of spontaneous and methylmethanesulfonate-induced trifluorothy-midine-resistant L5178Y cell colonies. Mutat Res 370:181-190, 1996.

7. M Liechty, Z Hassanpour, J Hozier, D Clive. Use of microsatellite DNA polymorphisms on mouse chromosome 11 for in vitro analysis of thymidine kinase gene mutations. Mutagenesis 9:423-427, 1994.

8. M Leichty, J Scalzi, K Sims, H Crosby Jr, D Spencer, L Davis, W Caspary, J Hozier. Analysis of large and small colony L5178Y tk+/- mouse lymphoma mutants by loss of heterozygosity (LOH) and by whole chromosome 11 painting: Detection of recombination. Mutagenesis 13:461-474, 1998.

9. J Hozier, M Applegate, MM Moore. In vitro mammalian mutagenesis as a model for genetic lesions in human cancer. Mutat Res 270:201-209, 1992.

10. D Clive, JFS Spector. Laboratory procedure for assessing specific locus mutations at the tk locus in cultured L5178Y mouse lymphoma cells. Mutat Res 31:17-29, 1975.

11. D Clive, KO Johnson, JFS Spector, AG Batson, MMM Brown. Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system. Mutat Res 59:61-108, 1979.

12. MM Moore-Brown, D Clive, BE Howard, AG Batson, KO Johnson. The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells. Mutat Res 85:363-378, 1981.

13. MM Moore, D Clive. The quantitation of TK-/- and HGPRT-mutants of L5178Y/ TK+/- mouse lymphoma cells at varying times post-treatment. Environ Mutagen 4:499-519, 1982.

14. MM Moore, BE Howard. Quantitation of small colony trifluorothymidine-resistant mutants of L5178Y/TK+/- mouse lymphoma cells in RPMI-1640 medium. Mutat Res 104:287-294, 1982.

15. J Cole, CF Arlett, MHL Green, J Lowe, W Muriel. A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cells. Mutat Res 111:371-386, 1983.

16. NT Turner, AG Batson, D Clive. Procedure for the L5178Y/TK+/- to TK-/- mouse lymphoma cell mutagenicity assay. In: BJ Kilbey, M Legator, W Nichols, C Ramel, eds. Handbook of Mutagenicity Test Procedures. Amsterdam: Elsevier Science Publishers, 1984, pp 239-268.

17. JB Majeska, DW Matheson. Development of an optimal S9 activation mixture for the L5178YTK+/- mouse lymphoma mutation assay. Environ Mol Mutagen 16:311-319, 1990.

18. DL Spencer, KC Hines, WJ Caspary. An in situ protocol for measuring the expression of chemically-induced mutations in mammalian cells. Mutat Res 312:85-97, 1994.

19. D Clive, G Bolcsfoldi, J Clements, J Cole, M Honma, J Majeska, M Moore, L Muller, B Myhr, T Oberly, MC Odelhkim, C Rudd, H Shimada, T Sofuni, V Thybaud, P Wilcox. Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, May 7, 1994. Environ Mol Mutagen 25:165168, 1995.

20. ML Garriott, DA Casciano, LM Schechtman, GS Probst. International workshop on mouse lymphoma assay testing practices and data interpretations: Portland, Oregon, May 7, 1994. Environ Mol Mutagen 25:162-164,

21. T Sofuni, M Honma, M Hayashi, H Shimada, N Tanaka, S Wakuri, T Awogi, KI Yamamoto, Y Nishi, M Nakadate. Detection of in vitro clastogens and spindle poisons by the mouse lymphoma assay using the microwell method: Interim report of an international collaborative study. Mutagenesis 11:349-355, 1996.

22. T Sofuni, P Wilcox, H Shimada, J Clements, M Honma, D Clive, M Green, V Thybaud, RHC San, BM Elliot, L Muller, L. Meeting report on protocol issues regarding the use of the microwell method discussed in the mouse lymphoma workshop: Victoria B.C., Canada, March 27, 1996. Environ Mol Mutagen 29:434-438, 1997.

23. M Honma, M Hayashi, H Shimada, N Tanaka, S Wakuri, T Awogi, KI Yamamoto, K, N Ushio-Kodani, Y Nishi, M Nakadate, T Sofuni. Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test. Mutagenesis 14:5-22, 1999.

24. M Honma, L-S Zhang, H Sakamoto, M Ozaki, K Takeshita, M Momose, M Hayashi, T Sofuni. The need for long-term treatment in the mouse lymphoma assay. Mutagenesis 14:23-29, 1999.

25. J Cole, DB McGregor, M Fox, J Thacker, RC Garner. Gene mutation assays in cultured mammalian cells. In: DJ Kirkland, ed. Basic Mutagenicity Tests. Avon: Cambridge University Press, 1990, pp 87-114.

26. J Cole, FN Richmond, BA Bridges. The mutagenicity of a-amino-N6-hydroxy-adenine to L5178Y tk+/- mouse lymphoma cells: Measurement of mutations to ouabain, 6-thioguanine and trifluorothymidine resistance, and the induction of micronuclei. Mutat Res 253:55-62, 1991.

27. P Clay, MF Cross. Microwell mutation assays: Evaluation of ethylmethansulfonate, benzo[a]pyrene and benzidine using the tk locus in L5178Y mouse lymphoma cells. Mutagenesis 5 (suppl):45-54, 1990

28. TJ Oberly, DL Yount, ML Garriot. A comparison of the soft agar and microtiter methodologies for the L5178Y tkĀ± mouse lymphoma assay. Mutat Res 388:59-66, 1997.

29. EM Furth, WG Thilly, BA Penman, HL Liber, WM Rand. Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. Anal Biochem 110:1-8, 1981.

30. WD Robinson, MHL Green, J Cole MJR Healy, RC Garner, D Gatehouse. Statistical evaluation of bacterial/mammalian fluctuation test. In: DJ Kirkland, ed. Statistical Evaluation of Mutagenicity Test Data. Cambridge: Cambridge University Press, 1989, pp 102-140.

31. M Hayashi, T Ohmori, Y Honda, M Honma, Y Nishi, T Awogi, Y Kasahara, N Tanaka, Y Nakagawa, S Wakuri, A Hirose, H Shimada, T Morita, A Wakata, T Sofuni, I Yoshimura. Statistical evaluation of the mammalian mutation assay data by mouse lymphoma L5178Y/tk microtitration method. Mutagenesis, 1999, (in press),

32. CF Arlett, DM Smith, GM Clarke, MHL Green, J Cole, DB McGregor, JC Asquith. Mammalian cell gene mutation assay based upon colony formation. In: DJ Kirkland, ed. Statistical Evaluation of Mutagenicity Test Data. Cambridge: Cambridge University Press, 1989, pp 102-140.

33. RD Storer, AR Kraynak, TW McKelvey, MC Elia, TL Goodrow, JG DeLuca. The mouse lymphoma L5178YTK+/- cell line is heterozygous for codon 170 mutation in the p53 tumor supressor gene. Mutat Res 373:157-165, 1997.

34. LS Clark, DW Hart, PJ Vojta, K Harrington-Brock, JC Barrett, MM Moore, KR Tindall. Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk+/-3.7.2C mouse lymphoma cells. Mutagenesis 13:427-434, 1998.

35. M Honma, M Hayashi, T Sofuni. Cytotoxic and mutagenic responses to X-rays and chemical mutagens in normal and p53-mutated human lymphoblastoid cells. Mutat Res 374:89-98, 1997

36. M Honma, L-S Zhang, M Hayashi, K Takeshita, Y Nakagawa, N Tanaka, T Sofuni. Illegitimate recombination leading to allelic loss and unbalanced translocation in p53-mutated human lymphoblastoid cells. Mol Cell Biol 17:4774-4781, 1997.

37. D Clive, NT Turner, R Krehl, J Eyre. The mouse lymphoma assay may also be used as a chromosome aberration assay. Environ Mutagen 7 (suppl 3):33, 1985.

0 0

Post a comment